Leserer, S.; Arrieta-Bolaños, E.; Buttkereit, U.; Beelen, D.W.; Turki, A.T.
Combined Analysis of Early CD4+ T Cell Counts and CMV Serostatus May Improve CMV Risk Assessment after Allogeneic Hematopoietic Cell Transplantation. Cells 2021, 10, 3318.
https://doi.org/10.3390/cells10123318
AMA Style
Leserer S, Arrieta-Bolaños E, Buttkereit U, Beelen DW, Turki AT.
Combined Analysis of Early CD4+ T Cell Counts and CMV Serostatus May Improve CMV Risk Assessment after Allogeneic Hematopoietic Cell Transplantation. Cells. 2021; 10(12):3318.
https://doi.org/10.3390/cells10123318
Chicago/Turabian Style
Leserer, Saskia, Esteban Arrieta-Bolaños, Ulrike Buttkereit, Dietrich W. Beelen, and Amin T. Turki.
2021. "Combined Analysis of Early CD4+ T Cell Counts and CMV Serostatus May Improve CMV Risk Assessment after Allogeneic Hematopoietic Cell Transplantation" Cells 10, no. 12: 3318.
https://doi.org/10.3390/cells10123318
APA Style
Leserer, S., Arrieta-Bolaños, E., Buttkereit, U., Beelen, D. W., & Turki, A. T.
(2021). Combined Analysis of Early CD4+ T Cell Counts and CMV Serostatus May Improve CMV Risk Assessment after Allogeneic Hematopoietic Cell Transplantation. Cells, 10(12), 3318.
https://doi.org/10.3390/cells10123318